The vicious cycle of BRASH syndrome: A case report.
Journal
Global cardiology science & practice
ISSN: 2305-7823
Titre abrégé: Glob Cardiol Sci Pract
Pays: Qatar
ID NLM: 101613130
Informations de publication
Date de publication:
30 Jan 2023
30 Jan 2023
Historique:
received:
12
11
2022
accepted:
10
01
2023
entrez:
9
3
2023
pubmed:
10
3
2023
medline:
10
3
2023
Statut:
epublish
Résumé
First described in 2016, BRASH syndrome is an underreported clinical entity characterized by bradycardia, renal dysfunction, atrioventricular nodal blockade (AVNB), shock, and hyperkalemia. The recognition of BRASH syndrome as a clinical entity is crucial for early and effective management. Patients with BRASH syndrome present with symptomatic bradycardia that is resistant to treatment with standard agents such as atropine. In this report, we present the case of a 67-year-old male patient who presented with symptomatic bradycardia with an ultimate diagnosis of BRASH syndrome. We also shed light on predisposing factors and challenges encountered during the management of affected patients.
Identifiants
pubmed: 36890842
doi: 10.21542/gcsp.2023.2
pii: gcsp.2023.2
pmc: PMC9988297
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e202302Informations de copyright
Copyright ©2023 The Author(s).
Références
J Emerg Med. 2020 Aug;59(2):216-223
pubmed: 32565167
Am J Case Rep. 2022 Jan 21;23:e934600
pubmed: 35058422
Mayo Clin Proc. 2021 Mar;96(3):744-762
pubmed: 33160639
Am Fam Physician. 2006 Jan 15;73(2):283-90
pubmed: 16445274
N Engl J Med. 2016 May 26;374(21):2009-20
pubmed: 27041480